This inventor holds 1 USPTO granted patent. Top assignees: Chinese Academy of Sciences, Shanghai Institute of Pharmaceutical Industry. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2014
Title: Haitao Mao: Innovator in Anti-HCV Medicaments
Introduction
Haitao Mao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-HCV medicaments. His innovative approach combines traditional Chinese medicine with modern scientific techniques.
Latest Patents
Haitao Mao holds a patent for the "Use of 9, 10-anthraquinone compounds." This patent discloses the use of 9,10-anthraquinone compounds or pharmaceutical salts thereof in the preparation of anti-HCV medicaments. The compounds are noted for being cheap, safe, and effective, primarily derived from traditional Chinese medicines. They exhibit better anti-HCV effects with lighter side effects compared to other treatments.
Career Highlights
Throughout his career, Haitao Mao has worked with esteemed institutions such as the Chinese Academy of Sciences and the Shanghai Institute of Pharmaceutical Industry. His work has been instrumental in advancing the understanding and treatment of HCV.
Collaborations
Haitao Mao has collaborated with notable colleagues, including Shuguang Wang and Chunyan Gai. Their combined expertise has contributed to the success of his research and innovations.
Conclusion
Haitao Mao's contributions to the field of pharmaceuticals, particularly in anti-HCV medicaments, highlight the importance of integrating traditional medicine with modern science. His innovative work continues to pave the way for effective treatments in the medical community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile